Defending Market Share in Pharma

Posted by Fuld + Company on Mar 18, 2016 9:49:49 AM

Pharmaceutical firms frequently need to defend their market position against rivals’ competitive strategy. Threats to leading therapies can come in many forms:

  • A structurally similar compound or generic variant is entering the market, aiming to compete with your brand on efficacy, safety, or price
  • A drug with a new mechanism of action has generated considerable excitement, and patients are expected to switch to the novel drug
  • An established product in a related indication may be moving into your market due to a label expansion
  • An existing competitor has begun targeting your product with negative claims

Competitive intelligence (CI) and strategic planning provide pharmaceutical firms with actionable counter-measures to protect market share, retain customers, and minimize the impact of aggressive direct competition:


Protect Market Share from New Market Entrants


Restrict Competitor Product Launch


Maintain Market Dominance


Fuld + Company helps clients defend market share through the following services:


 Our analysts have experience in a variety of therapeutic areas:

 Fuld + Co. Life Sciences Expertise

Additional micro case studies of successful market position defense (click to expand):

Protect Market Share amidst Generic Launch     MCS002     MCS009


Topics: Competitive Intelligence, Fuld + Company, Pharma, Healthcare, Life Cycle Management, Life Sciences, Competitive Strategy

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.